Comprehensive genome analysis of 6,000 USA SARS-CoV-2 isolates reveals haplotype signatures and localized transmission patterns by state and by country

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was partially supported by the Children's Hospital Los Angeles internal COVID-19 pilot study "Genomic Epidemiology Study of COVID-19 in Los Angeles" (PI: Dien Bard).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Data used in the study were mostly anonymized and deposited at publicly accessible databases GISAID and NCBI GenBank by researcher across the world. Additional CHLA viral samples were studied under an IRB approved study (CHLA-16-00429-AM002; PI: Dien Bard)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes